Article thumbnail

The Orphan Nuclear Receptor SHP Is a Positive Regulator of Osteoblastic Bone Formation

By Byung-Chul Jeong, Yong-Soo Lee, In-Ho Bae, Chul-Ho Lee, Hong-In Shin, Hyun Jung Ha, Renny T Franceschi, Hueng-Sik Choi and Jeong-Tae Koh

Abstract

The orphan nuclear receptor small heterodimer partner (SHP; NR0B2) interacts with a diverse array of transcription factors and regulates a variety of cellular events such as cell proliferation, differentiation, and metabolism. However, the role of SHP in bone formation has not yet been elucidated. SHP expression is significantly increased during osteoblast differentiation, and its expression is partially regulated by bone morphogenetic protein 2 (BMP-2), which plays an important role in bone formation. In our study, inhibition of SHP expression significantly repressed BMP-2-induced osteoblast differentiation and ectopic bone formation. In accordance with these in vitro and in vivo results, osteoblast differentiation in SHP−/− mice primary osteoblasts was significantly repressed, and the mice showed decreased bone mass resulting from decreased numbers of osteoblasts. Finally, SHP physically interacts and forms a complex with runt-related transcription factor 2 (Runx2) on the osteocalcin gene promoter, and overexpression of SHP increased Runx2 transactivity via competition with histone deacetylase 4 (HDAC4), an enzyme that inhibits DNA binding of Runx2 to its target genes. Taken together, these results indicate that SHP acts as a novel positive regulator of bone formation by augmenting osteoblast differentiation through regulation of the transcriptional activity of Runx2. © 2010 American Society for Bone and Mineral Researc

Topics: Original Article
Publisher: Wiley Subscription Services, Inc., A Wiley Company
OAI identifier: oai:pubmedcentral.nih.gov:3153384
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1999). A WW domaincontaining yes-associated protein (YAP) is a novel transcriptional coactivator.
  2. (2007). Adamantyl-substituted retinoidrelated molecules bind small heterodimer partner and modulate the Sin3A repressor. Cancer Res.
  3. (1996). An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors.
  4. Androgen receptor stimulates bone sialoprotein (BSP) gene transcription via cAMP response element and activator protein 1/glucocorticoid response elements.
  5. Bile acid induces expression of COX-2 through the homeodomain transcription factor CDX1andorphannuclearreceptorSHPinhumangastriccancercells.
  6. (2006). BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype. J Bone Miner Res.
  7. BMP-2 activity, although dispensable for bone formation, is required for the initiation of fracture healing.
  8. (1991). Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochem Biophys Res Commun.
  9. Building bone to reverse osteoporosis and repair fractures.
  10. (1999). Cbfa1 isoforms exert functional differences in osteoblast differentiation.
  11. ChenY,BhushanA,ValeW.Smad8mediatesthesignalingoftheALK2 [corrected] receptor serine kinase.
  12. Control of osteoblast function and regulation of bone mass.
  13. Deftos LJ. 1,25-Dihydroxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-like cells.
  14. (1997). Dependence of mesenchymal cell responses on duration of exposure to bone morphogenetic protein-2 in vitro.
  15. Estrogen prevents bone loss via estrogen receptor a and induction of Fas ligand in osteoclasts.
  16. Estrogen receptor-related receptor a (ERRa) regulates osteopontin expression through a non-canonical ERRa response element in a cell context-dependent manner.
  17. (1993). Expressionofhuman bonemorphogenetic proteins-2or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol.
  18. (2003). Genetic regulation of osteoclast development and function. Nat Rev Genet.
  19. Glucotoxicity in the INS-1 rat insulinoma cell line is mediated by the orphan nuclear receptor small heterodimer partner.
  20. Hepatocyte growth factor signaling pathway inhibits cholesterol 7a-hydroxylase and bile acid synthesis in human hepatocytes.
  21. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis.
  22. Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis.
  23. Metformin inhibits hepatic gluconeogenesisthroughAMP-activatedproteinkinase-dependentregulation of the orphan nuclear receptor SHP.
  24. Molecular basis of endocrine regulation by orphan nuclear receptor small heterodimer partner.
  25. Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver.
  26. (1999). Multilineage potential of adult human mesenchymal stem cells.
  27. Orphan nuclear receptor SHP interacts with and represses hepatocyte nuclear factor-6 (HNF-6) transactivation.
  28. (2004). Orphannuclearreceptor smallheterodimer partner represses hepatocyte nuclear factor 3/Foxa transactivation via inhibition of its DNA binding. Mol Endocrinol.
  29. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation.
  30. Reciprocal roles of MSX2 in regulation of osteoblast and adipocyte differentiation.
  31. Regulation of osteoblast differentiation by transcription factors.
  32. (2000). Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev.
  33. Regulation of skeletal development by the Runx family of transcription factors.
  34. (2003). Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity. Mol Cell Biol.
  35. (1997). Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex.
  36. Runx2 is a commontarget of transforming growth factor b1 and bone morphogenetic protein 2, and cooperation between
  37. Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice.
  38. Small heterodimer partner, an orphan nuclear receptor, augments peroxisome proliferator-activated receptor gamma transactivation.
  39. StifaniS.ThemammalianbasichelixloophelixproteinHES-1bindsto and modulates the transactivating function of the runt-related factor Cbfa1.
  40. (1998). Structure and expression of the orphan nuclear receptor SHP gene.
  41. (2007). Structure and function of the atypical orphan nuclear receptor small heterodimer partner. Int Rev Cytol.
  42. Toward a molecular understanding of skeletal development.
  43. Transcriptional regulation of osteoblasts.
  44. Two of four alternatively spliced isoforms of RUNX2 control osteocalcin gene expression in human osteoblast cells.